Ibuprofen

Generic Name
Ibuprofen
Brand Names
Addaprin, Advil, Advil Cold and Sinus, Advil Congestion Relief, Advil PM, Advil Sinus Congestion and Pain, Alivio, Caldolor, Cedaprin, Children's Ibuprofen, Diphen, Duexis, Ibu, Ibutab, Junior Strength Motrin, Motrin, Motrin PM, Neoprofen, Nuprin, Pedea, Proprinal, Reprexain, Sudafed PE Head Congestion Plus Pain, Vicoprofen, Wal-profen Congestion Relief and Pain, Ibuprofen Gen.Orph
Drug Type
Small Molecule
Chemical Formula
C13H18O2
CAS Number
15687-27-1
Unique Ingredient Identifier
WK2XYI10QM
Background

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.

On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.

Indication

Ibuprofen is the most commonly used and prescribed NSAID. It is a very common over-the-counter medication widely used as an analgesic, anti-inflammatory and antipyretic.

The use of ibuprofen and its enantiomer Dexibuprofen in a racemic mix is common for the management of mild to moderate pain related to dysmenorrhea, headache, migraine, postoperative dental pain, spondylitis, osteoarthritis, rheumatoid arthritis, and soft tissue disorder.

Due to its activity against prostaglandin and thromboxane synthesis, ibuprofen has been attributed to alteration of platelet function and prolongation of gestation and labour.

As ibuprofen is a widely used medication, the main therapeutic indications are:

Associated Conditions
Acute Pain, Ankylosing Spondylitis (AS), Common Cold, Cystic Fibrosis (CF), Fever, Gastric Ulcer, Gout, Headache, Insomnia, Juvenile Idiopathic Arthritis (JIA), Menstrual Distress (Dysmenorrhea), Migraine, Mild pain, Nasal Congestion, Osteoarthritis (OA), Pain, Pain, Inflammatory, Patent Ductus Arteriosus (PDA), Pericarditis, Primary Dysmenorrhoea, Rheumatoid Arthritis, Severe Pain, Sinus pressure, Mild to moderate pain, Minor aches and pains, Moderate Pain
Associated Therapies
-

Analysis of the Effects of the Osteopathic Manipulative Treatment in Carriers of Temporomandibular Disorders

First Posted Date
2016-11-28
Last Posted Date
2016-11-28
Lead Sponsor
Instituto Brasileiro de Osteopatia
Target Recruit Count
32
Registration Number
NCT02974166
Locations
🇧🇷

Brazilian Institute of Osteopathy, Porto Alegre, Rio Grande do Sul, Brazil

Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2016-11-15
Last Posted Date
2018-09-27
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
56
Registration Number
NCT02963701
Locations
🇿🇦

Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa), Bloemfontein, South Africa

Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat

First Posted Date
2016-10-18
Last Posted Date
2018-06-01
Lead Sponsor
USDA, Western Human Nutrition Research Center
Target Recruit Count
14
Registration Number
NCT02935894
Locations
🇺🇸

Western Human Nutrition Research Center, Davis, California, United States

Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes

First Posted Date
2016-10-13
Last Posted Date
2022-03-16
Lead Sponsor
University of Rochester
Target Recruit Count
59
Registration Number
NCT02932579
Locations
🇺🇸

Eastman Institute for Oral Health, Rochester, New York, United States

Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy

First Posted Date
2016-10-11
Last Posted Date
2024-03-26
Lead Sponsor
Mike O'Callaghan Military Hospital
Target Recruit Count
18
Registration Number
NCT02929589
Locations
🇺🇸

Mike O'Callaghan Federal Medical Center, Nellis Air Force Base, Nevada, United States

Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features

First Posted Date
2016-09-22
Last Posted Date
2023-07-27
Lead Sponsor
University of New Mexico
Target Recruit Count
100
Registration Number
NCT02911701
Locations
🇺🇸

University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States

Impact of Extra Virgin Olive Oil Oleocanthal Content on Platelet Reactivity

First Posted Date
2016-09-16
Last Posted Date
2021-04-27
Lead Sponsor
University of California, Davis
Target Recruit Count
9
Registration Number
NCT02902913

The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy

First Posted Date
2016-09-07
Last Posted Date
2019-05-23
Lead Sponsor
University of Michigan
Target Recruit Count
74
Registration Number
NCT02891174
Locations
🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

Early Treatment Versus Expectative Management of PDA in Preterm Infants

First Posted Date
2016-08-30
Last Posted Date
2023-07-03
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
273
Registration Number
NCT02884219
Locations
🇳🇱

Radboudumc Amalia Children's Hospital, Nijmegen, Netherlands

🇧🇪

University Hospital Antwerp, Antwerp, Belgium

🇧🇪

University Hospital Brussels, Brussels, Belgium

and more 10 locations

A Dental Pain Study Comparing The Analgesic Efficacy Of Ibuprofen/Caffeine

Phase 3
Completed
Conditions
Interventions
First Posted Date
2016-08-11
Last Posted Date
2019-04-08
Lead Sponsor
Pfizer
Target Recruit Count
374
Registration Number
NCT02863575
Locations
🇺🇸

Jean Brown Research, Salt Lake City, Utah, United States

© Copyright 2024. All Rights Reserved by MedPath